Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, November 26, 2014
Technology Networks
 
Register | Sign in
Home Page>Latest Webcasts

  Webcasts

Scientific News
Themis Bioscience’s Vaccine Against Chikungunya Successful in Phase 1
Results presented at international conferences in Philadelphia and New Orleans.
Novel Cancer Vaccine Approach for Brain Tumors
Researchers unravel the mechanisms behind a novel cancer vaccine for brain tumors, paving the way for further development.
Computer Model Sets New Precedent in Drug Discovery
New computational model can precisely simulate, predict therapeutic protein behaviors to help zero in on ideal drug design candidates.
UCLA Biochemists Build Largest Synthetic Molecular ‘Cage’ Ever
New nanoscale protein container could lead to synthetic vaccines and offer a way to deliver medicine inside of human cells.
Large-scale Study Raises Hopes For Development Of E. coli Vaccine
Global comparison reveals surprisingly close relation between E. coli strains that cause traveller's diarrhoea.
Typhoid Gene Unravelled
Natural resistance against typhoid fever is linked to a particular form of the HLA-DRB1 gene.
Making Vaccines More Effective In The Elderly
Compound shown to restore the immune system’s inbuilt memory.
Developing Lifesaving Vaccines in a New Way
Rutgers-led immune system research also may help reveal new asthma clues.
New Vaccine Generates Strong Immune Response Against Hepatitis C
A new hepatitis C vaccine has shown promising results in an early clinical trial at Oxford University, generating strong and broad immune responses against the virus causing the disease.
Inhaled Ebola Vaccine May Offer Long-Term Protection from Virus
A potentially breathable, respiratory vaccine in development has been shown to provide long-term protection for non-human primates against the deadly Ebola virus.

Glycosylation of IgG antibodies: a Critical Quality Attribute (CQA)
Professor Roy Jefferis, College of Medical and Dental Sciences, University of Birmingham, speaking at BioProcessing, Biologics & Biotherapeutics Congress 2011.

Continuous Chromatography (MCSGP) for the Purification of Therapeutic Proteins
Dr Thomas Müller-Späth, ETH Switzerland, speaking at BioProcessing, Biologics & Biotherapeutics Congress 2011.

Biosimilars and the US-legislation: Analytical and Clinical Challenges
Dr William Egan, Vice President in the Consulting Division of PharmaNet, speaking at BioProcessing, Biologics & Biotherapeutics Congress 2011.

Actionable Biomarkers for Rheumatoid Arthritis
Dr William Robinson, Stanford University, speaking at Microarray World Congress 2011.

Background and Key Drivers Leading to Clinical Immunogenicity
Dr Matthew Baker, Chief Scientific Officer at Antitope Ltd, speaking at Bioprocessing, Biologics and Biotherapeutics 2011.

Thinking Small so as to Gain the Bigger Picture: Progress in High Throughput Bioprocess Development
Professor Nigel Titchener-Hooker, University College London, speaking at Bioprocessing, Biologics and Biotherapeutics Congress 2011.

Antibody Fragments - New Approaches for Production
Dr John Lidell, FujiFilm, speaking at BioProcessing, Biologics & Biotherapeutics Congress 2011.

EU Regulatory Landscape for Approval of Biosimilars
Dr Lincoln Tsang, Arnold and Porter LLP, speaking at BioProcessing, Biologics & Biotherapeutics Congress / Stem Cells Europe 2011.

Modeling and Prediction of Antibody Chromatography Purification
Professor Christian Frech, Mannheim University of Applied Science, speaking at BioProcessing, Biologics and Biotherapeutics Congress.

<< 1 2 3 4 >>
Showing Results 21 - 30 of 31
Skyscraper Banner
SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv